Dimitri P, Roth C
J Endocr Soc. 2024; 9(1):bvae200.
PMID: 39703362
PMC: 11655849.
DOI: 10.1210/jendso/bvae200.
Tatachar S, Rajan R, Hesaraghatta Shyamsunder A, Kapoor N
Obes Pillars. 2024; 12:100139.
PMID: 39431051
PMC: 11489328.
DOI: 10.1016/j.obpill.2024.100139.
Cuda S, Censani M, OHara V, Paisley J, Kharofa R, Conroy R
Obes Pillars. 2024; 11:100113.
PMID: 38953014
PMC: 11216014.
DOI: 10.1016/j.obpill.2024.100113.
Han Y, Wang Y, Li S, Sato K, Yamagishi S
PLoS One. 2024; 19(6):e0304404.
PMID: 38848397
PMC: 11161051.
DOI: 10.1371/journal.pone.0304404.
Roth C, Zenno A
Front Endocrinol (Lausanne). 2023; 14:1256514.
PMID: 37780616
PMC: 10533996.
DOI: 10.3389/fendo.2023.1256514.
Long-term outcomes in patients with adult-onset craniopharyngioma.
Dogra P, Bedatsova L, Van Gompel J, Giannini C, Donegan D, Erickson D
Endocrine. 2022; 78(1):123-134.
PMID: 35869972
PMC: 9308022.
DOI: 10.1007/s12020-022-03134-4.
Treatment of Acquired Hypothalamic Obesity: Now and the Future.
Dimitri P
Front Endocrinol (Lausanne). 2022; 13:846880.
PMID: 35464063
PMC: 9019363.
DOI: 10.3389/fendo.2022.846880.
Novel clinical algorithm for hypothalamic obesity in youth with brain tumours and factors associated with excess weight gain.
Rydin A, Severn C, Pyle L, Dorris K, Chambers C, Stiller D
Pediatr Obes. 2022; 17(7):e12903.
PMID: 35224874
PMC: 10038012.
DOI: 10.1111/ijpo.12903.
Radiotherapy alone for pediatric patients with craniopharyngioma.
Young M, Delaney A, Jurbergs N, Pan H, Wang F, Boop F
J Neurooncol. 2021; 156(1):195-204.
PMID: 34846639
DOI: 10.1007/s11060-021-03908-2.
Risk Factors for Hypothalamic Obesity in Patients With Adult-Onset Craniopharyngioma: A Consecutive Series of 120 Cases.
Wu W, Sun Q, Zhu X, Xiang B, Zhang Q, Miao Q
Front Endocrinol (Lausanne). 2021; 12:694213.
PMID: 34394000
PMC: 8355989.
DOI: 10.3389/fendo.2021.694213.
Multidisciplinary Approach for Hypothalamic Obesity in Children and Adolescents: A Preliminary Study.
Tessaris D, Matarazzo P, Tuli G, Tuscano A, Rabbone I, Spinardi A
Children (Basel). 2021; 8(7).
PMID: 34206290
PMC: 8304472.
DOI: 10.3390/children8070531.
Preoperative BMI Predicts Postoperative Weight Gain in Adult-onset Craniopharyngioma.
Duan D, Wehbeh L, Mukherjee D, Hamrahian A, Rodriguez F, Gujar S
J Clin Endocrinol Metab. 2021; 106(4):e1603-e1617.
PMID: 33417676
PMC: 7993568.
DOI: 10.1210/clinem/dgaa985.
Diagnosis, Background, and Treatment of Hypothalamic Damage in Craniopharyngioma.
Erfurth E
Neuroendocrinology. 2020; 110(9-10):767-779.
PMID: 32580186
PMC: 7490511.
DOI: 10.1159/000509616.
Genetic and immune profiling for potential therapeutic targets in adult human craniopharyngioma.
Kassab C, Zamler D, Kamiya-Matsuoka C, Gatalica Z, Xiu J, Spetzler D
Clin Oncol Res. 2019; 2(3):2-8.
PMID: 31712784
PMC: 6844364.
DOI: 10.31487/j.COR.2019.03.05.
Periostin concentrations in childhood-onset craniopharyngioma patients.
Heinks K, De Schutter-Nusse C, Boekhoff S, Bogusz A, Zhu J, Peng J
J Endocrinol Invest. 2018; 42(7):815-824.
PMID: 30474798
DOI: 10.1007/s40618-018-0987-9.
Pediatric Craniopharyngiomas: A Primer for the Skull Base Surgeon.
Graffeo C, Perry A, Link M, Daniels D
J Neurol Surg B Skull Base. 2018; 79(1):65-80.
PMID: 29404243
PMC: 5796826.
DOI: 10.1055/s-0037-1621738.
Fractionated stereotactic radiotherapy with static field conformal and non coplanar arcs for pediatric patients with craniopharyngioma: analysis of long term visual outcome and endocrine toxicity.
Pica A, Abbeel S, von der Weid N, Sajadi A, Negretti L, Phan-Hug F
J Radiosurg SBRT. 2018; 2(3):209-216.
PMID: 29296363
PMC: 5658812.
Radiological presentation of chondromyxoid fibroma in the sellar region: A CARE-compliant article and literature review.
Shen S, Chen M, Jug R, Yu C, Zhang W, Yang L
Medicine (Baltimore). 2017; 96(49):e9049.
PMID: 29245307
PMC: 5728922.
DOI: 10.1097/MD.0000000000009049.
Risk-adapted, long-term management in childhood-onset craniopharyngioma.
Muller H
Pituitary. 2016; 20(2):267-281.
PMID: 27604996
DOI: 10.1007/s11102-016-0751-0.
Hypothalamic Obesity in Craniopharyngioma Patients: Disturbed Energy Homeostasis Related to Extent of Hypothalamic Damage and Its Implication for Obesity Intervention.
Roth C
J Clin Med. 2015; 4(9):1774-97.
PMID: 26371051
PMC: 4600159.
DOI: 10.3390/jcm4091774.